Studies a cardiac scale to predict fluid overload in people on peritoneal dialysis
Explores a cardiac scale to predict fluid overload events in adults with kidney disease.
Plain-language title generated from the registry record
Registry title: Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
Key facts
- Where
- Augusta, Chicago, Nashville, and Victorville, United StatesSee the 4 sites
Where in United States
- Southeastern Clinical Research InstituteAugusta, United StatesTaking people
- Northwestern UniversityChicago, United StatesTaking people
- Vanderbilt University Medical CenterNashville, United StatesTaking people
- Desert Cities DialysisVictorville, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Bodyport Inc.
- Trial code
- NCT07059962
- Record updated
- 22 October 2026
- Original description
To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.Read full original descriptionShow less
Sensor-based Congestion Alert for Events in Peritoneal Dialysis (SCALE-PD)
To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.
Inclusion: Age 21 years or older; Able to speak and read English, or able to speak and read Spanish and has a caregiver or family member who speaks English and can provide assistance; Able to stand on two bare feet unassisted; Receiving automated peritoneal dialysis for the treatment of ESKD; Followed on the Vantive Sharesource Remote Patient Management Platform.
Exclusion: Planned kidney transplant within the next 12 months; Undergoing or plan to undergo hemodialysis in the next 12 months; Have a life expectancy of less than 12 months; Are pregnant or plan to become pregnant during the next 12 months; Weigh greater than 375 lbs; Have an implanted neurostimulator system.